Literature DB >> 18494061

Significance of Bcl-xL in human colon carcinoma.

You-Li Zhang1, Li-Qun Pang, Ying Wu, Xiao-Yan Wang, Chong-Qiang Wang, Yu Fan.   

Abstract

AIM: To investigate the clinical significance of Bcl-xL gene in the pathogenesis of human colon carcinoma.
METHODS: Fifty-six pair tissue samples from patients with colon cancer were collected, and protein level of the Bcl-xL gene was measured by immunohistochemistry method. The correlation of Bcl-xL expression with clinical index was evaluated. After human colon cancer cell line HT29 was transfected with Bcl-xL small interfering RNA (siRNA), the anchorage-independent growth of cancer cells was detected by colony formation in soft agar and invasion ability of cancer cells was determined by a transwell model.
RESULTS: The Bcl-xL expression was higher in cancerous tissue samples than in normal tissue samples (38.78 +/-11.36 vs 0.89 +/- 0.35, P < 0.001), and was associated with the pathological grade, lymph node metastasis and Duke's stage of colorectal carcinoma. Transfection with Bcl-xL siRNA inhibited the colony formation and invasion ability of human colon cancer cell line HT29 in vitro.
CONCLUSION: Bcl-xL gene plays an important role in carcinogenesis of human colorectal carcinoma and is associated with malignant biological behaviors of human colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494061      PMCID: PMC2712177          DOI: 10.3748/wjg.14.3069

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

2.  Colorectal cancer screening: clinical guidelines and rationale.

Authors:  S J Winawer; R H Fletcher; L Miller; F Godlee; M H Stolar; C D Mulrow; S H Woolf; S N Glick; T G Ganiats; J H Bond; L Rosen; J G Zapka; S J Olsen; F M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; R J Mayer
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

3.  Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).

Authors:  A Frankel; K Rosen; J Filmus; R S Kerbel
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

4.  Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression.

Authors:  X Zhang; Q Xu; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma.

Authors:  Hai-Yan Tan; Jun Liu; Shan-Min Wu; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 7.  Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer.

Authors:  M Shike; S J Winawer; P H Greenwald; A Bloch; M J Hill; S V Swaroop
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

8.  Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.

Authors:  S G Sánchez-Ceja; E Reyes-Maldonado; M E Vázquez-Manríquez; J J López-Luna; A Belmont; S Gutiérrez-Castellanos
Journal:  Lung Cancer       Date:  2006-09-07       Impact factor: 5.705

9.  Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria.

Authors:  M G Vander Heiden; N S Chandel; E K Williamson; P T Schumacker; C B Thompson
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

10.  Inhibition of signal transducer and activator of transcription 3 expression by RNA interference suppresses invasion through inducing anoikis in human colon cancer cells.

Authors:  Yu Fan; You-Li Zhang; Ying Wu; Wei Zhang; Yin-Huan Wang; Zhao-Ming Cheng; Hua Li
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more
  21 in total

1.  Functions and regulation of MUC13 mucin in colon cancer cells.

Authors:  Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan
Journal:  J Gastroenterol       Date:  2013-10-07       Impact factor: 7.527

2.  The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.

Authors:  M Sarkar; V Khare; M K Ghosh
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

3.  Bax protein may influence the invasion of colorectal cancer.

Authors:  Anna Pryczynicz; Mariusz Gryko; Katarzyna Niewiarowska; Dariusz Cepowicz; Marek Ustymowicz; Andrzej Kemona; Katarzyna Guzińska-Ustymowicz
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

4.  Targeted disruption of Bcl-xL in mouse keratinocytes inhibits both UVB- and chemically induced skin carcinogenesis.

Authors:  Dae Joon Kim; Ken Kataoka; Shigetoshi Sano; Kevin Connolly; Kaoru Kiguchi; John DiGiovanni
Journal:  Mol Carcinog       Date:  2009-10       Impact factor: 4.784

5.  How many diseases are colorectal cancer?

Authors:  A Greystoke; S A Mullamitha
Journal:  Gastroenterol Res Pract       Date:  2012-09-09       Impact factor: 2.260

6.  Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells.

Authors:  Jinsong Yang; Ming Sun; Aiping Zhang; Chengyu Lv; Wei De; Zhaoxia Wang
Journal:  World J Surg Oncol       Date:  2011-10-04       Impact factor: 2.754

7.  The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma.

Authors:  Seung Woo Lee; Young Yong Ahn; Yon Soo Kim; Sang Beum Kang; Soon Woo Nam; Dong Soo Lee; Hyun Yong Jeong; Jin Man Kim
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

8.  Evidence for two modes of synergistic induction of apoptosis by mapatumumab and oxaliplatin in combination with hyperthermia in human colon cancer cells.

Authors:  Xinxin Song; Seog-Young Kim; Yong J Lee
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps.

Authors:  Rosimeri Kühl Svoboda Baldin; Carmen Austrália Paredes Marcondes Ribas; Lúcia de Noronha; Claudia Caroline Veloso da Silva-Camargo; Vanessa Santos Sotomaior; Ana Paula Martins Sebastião; Ana Paula Vasconcelos de Castilho; Mário Rodrigues Montemor Netto
Journal:  J Histochem Cytochem       Date:  2021-06-15       Impact factor: 4.137

10.  Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells.

Authors:  Bruno Christian Koehler; Anna-Lena Scherr; Stephan Lorenz; Christin Elssner; Nicole Kautz; Stefan Welte; Dirk Jaeger; Toni Urbanik; Henning Schulze-Bergkamen
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.